Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy
Dianne Stephens(Flinders University), Vasilios Koulouras(University Hospital of Ioannina), Sine Donnellan(Dunedin Public Hospital), Janattul‐Ain Jamal(Hospital Tengku Ampuan Afzan), Alejandro Rodríguez(Institut de Recerca Biomèdica Catalunya Sud), Claire Roger(Université de Montpellier), João Pedro Baptista(Hospitais da Universidade de Coimbra), Mireia Llauradó‐Serra(Universitat Internacional de Catalunya), Irma Bilgrami(Royal Darwin Hospital), Patricia Leung(Chinese University of Hong Kong), Mohd Basri Mat Nor(International Islamic University Malaysia), Otto Frey, Ignacio Martín‐Loeches(St. James's Hospital), Salmaan Kanji(Ottawa Hospital), Darren M. Roberts(Royal Prince Alfred Hospital), Rebecca Gresham(Nepean Hospital), Mahipal Sinnollareddy(University of South Australia), Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Anka C. Roehr(Australian and New Zealand Intensive Care Society), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Sandra Peake(Queen Elizabeth Hospital), Glenn M. Eastwood(Austin Hospital), Yugan Mudaliar(Westmead Hospital), Christina Koenig(Universität Hamburg), Louise Cole(The University of Sydney), Clément Boidin(Université Claude Bernard Lyon 1), Dolors Soy(Hospital Clínic de Barcelona), Michael S. Roberts(Auburn University), Leonardo Seoane(Ochsner Health System), Brent Richards(McGill University), Melissa Lassig‐Smith(Royal Brisbane and Women's Hospital), Marlies Ostermann(St Thomas' Hospital), Alexander Brinkmann, Sanjoy K. Paul(University of Leicester), Stefan Kluge(Universität Hamburg), Gavin M. Joynt(Chinese University of Hong Kong), Jean‐Yves Lefrant(Université de Montpellier), Sylvain Goutelle(Université Claude Bernard Lyon 1), Marta Ulldemolins(Bellvitge University Hospital), Xin Liu(Chengdu University of Traditional Chinese Medicine), Pedro Castro(Hospital Clínic de Barcelona), Anna Lee(Chinese University of Hong Kong), Gordon Choi, Eduardo Sousa(Instituto Dante Pazzanese de Cardiologia), Renae Deans(The University of Queensland), Katie Lei(University of Edinburgh), Jan J. De Waele(Ghent University Hospital), Anna Spring(Athens Naval & Veterans Hospital)
Cited by 11
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k